Skip to main content
. 2023 Jul 13;24(14):11390. doi: 10.3390/ijms241411390

Figure 3.

Figure 3

(A) The complex formed by the compound nilotinib and Mpro. (B) The interaction between the compound nilotinib and the Mpro residues.